...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Two More Promissory Notes
1
Oct 25, 2024 07:16AM

The Team getting their Xmas bonuses ready for all that work going on in the back ground......wink,,wink,,,,,, :o) ,,,,,while the 3rd parties do the heavy lifting with the research and trials,,,,,!!,,you cant make this stuiff up!!,,,ZzzzzZzzzzzZzzzzzzZzzzzzz,,,its a sleeper,,,,,,,it should be an embarrassment for our Team!,,and one need not think the biotech world along with its sauvy investing entities are oblivious to our slackness within!,,Jmo.

I wonder if we could have saved a life if we had put an aggressive bio business plan into action?,,and avoided seen as been greedy!!,,,,thats if anything we are pushing actually works as thought/designed!,,We possibly have allowed a somewhat forgotten group to perish needlessly,,,,that will be seen as history will write such into the pages..again,,,Jmo.

Share
New Message
Please login to post a reply